NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Braingaze

Braingaze

Private
LondonHealthcare & Life Scienceshttps://www.braingaze.com/

Last Round

Seed

Mar 6, 2024

Total Funding Raised

$2.37M

Company Overview

Braingaze is a healthtech company that provides objective, clinically validated tools for the diagnosis, treatment, and monitoring of ADHD and other neurodevelopmental conditions using eye-movement biomarker analysis and AI.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Medical AI, Medical Devices, Computer Vision

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

ADHD diagnosiseye-tracking biomarkersdigital diagnosticsneurotechdigital therapeuticsAI medical diagnosisgamified therapyclinical decision supporteye tracking technologyobjective diagnosismental health techdigital biomarkersautism diagnosisneurodevelopmental disordersgaze-controlled games

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Braingaze Comparables

Compare Braingaze with similar companies based on industry and business-model similarity.

Braingaze comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Qbtech
81%
The TOVA Company
79%
EarliPoint Health
77%

Braingaze Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 6, 2024
GrantAug 15, 2019
CrowdfundingJun 3, 2016
Pre SeedJul 23, 2014

Key People

Founding team and executive leadership

Hans Supèr

Co-Founder & CTO

Founding Team

Braingaze Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2025

    Monthly visitors increased 184% MoM.

  • Oct 28, 2024

    Monthly visitors grew 98% MoM.

Braingaze Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Braingaze Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Braingaze's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range9
Year Founded2013
Last FundingMar 6, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.